Early posttrabeculectomy IOP spike not associated with subsequent VF loss

Article

It has been reported in a recent study that early posttrabeculectomy intraocular pressure (IOP) spike was not linked with subsequent visual field (VF) loss in patients of the Collaborative Initial Glaucoma Treatment Study.

It has been reported in a recent study published in the Journal of Glaucoma that early posttrabeculectomy intraocular pressure (IOP) spike was not linked with subsequent visual field (VF) loss in patients of the Collaborative Initial Glaucoma Treatment Study.

Dr Philip P. Chen, Department of Ophthalmology, University of Washington, Seattle, Washington, USA, led the study aimed at determining the effect of early post-op IOP spike in patients in the Collaborative Initial Glaucoma Treatment Study who have had primary trabeculectomy.

The surgeons determined which patients had an IOP spike of more than or equal to 5 mmHg above baseline one day after surgery as well as those patients that did not experience an increase in IOP. Follow-up was then performed at 6 months, 1, 2, 3 and 5 years post surgery and the mean deviation (MD), pattern standard deviation (PSD) and corrected PSD of the patients VF were measured along with the IOP.

Out of the 300 patients in the study group 17 had an IOP spike. The clinicians compared the groups MD, PSD and corrected PSD, controlling for baseline VF severity, and found that there was no significant difference at each of the follow up points. However, a significantly higher difference was noted in the mean IOP after 3 and 5 years in the patients who had experienced a spike post-op.

It was determined that there was no association with a post-op IOP spike of more than or equal to 5 mmHg to VF loss after primary trabeculectomy surgery but there was an association with higher IOP levels at the longer follow up periods in Collaborative Initial Glaucoma Treatment Study patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.